| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 6.81e-06 | 17 | 5 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 6.81e-06 | 17 | 5 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 2.61e-04 | 103 | 5 | 2 | GO:0004725 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 8.75e-04 | 189 | 5 | 2 | GO:0004721 | |
| GeneOntologyMolecularFunction | phosphatase activity | 2.00e-03 | 287 | 5 | 2 | GO:0016791 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 3.59e-03 | 386 | 5 | 2 | GO:0042578 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 8.46e-03 | 599 | 5 | 2 | GO:0050839 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 1.50e-02 | 807 | 5 | 2 | GO:0016788 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine phosphatase signaling pathway | 9.87e-07 | 7 | 5 | 2 | GO:0007185 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 4.03e-05 | 42 | 5 | 2 | GO:0099560 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 1.03e-04 | 67 | 5 | 2 | GO:0050775 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 1.10e-04 | 69 | 5 | 2 | GO:0010770 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 2.45e-04 | 103 | 5 | 2 | GO:0048814 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 5.18e-04 | 150 | 5 | 2 | GO:0050773 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 7.86e-04 | 185 | 5 | 2 | GO:0099175 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 9.00e-04 | 198 | 5 | 2 | GO:0048813 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 1.50e-03 | 256 | 5 | 2 | GO:0006470 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 2.08e-03 | 302 | 5 | 2 | GO:0022604 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.23e-03 | 313 | 5 | 2 | GO:0098742 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 2.23e-03 | 313 | 5 | 2 | GO:0099173 | |
| GeneOntologyBiologicalProcess | dendrite development | 2.55e-03 | 335 | 5 | 2 | GO:0016358 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 2.62e-03 | 1366 | 5 | 3 | GO:0051130 | |
| GeneOntologyBiologicalProcess | dephosphorylation | 2.73e-03 | 347 | 5 | 2 | GO:0016311 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 2.84e-03 | 354 | 5 | 2 | GO:0050769 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 3.38e-03 | 387 | 5 | 2 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 3.52e-03 | 395 | 5 | 2 | GO:0050803 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 3.93e-03 | 418 | 5 | 2 | GO:0051962 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 5.46e-03 | 494 | 5 | 2 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 5.92e-03 | 515 | 5 | 2 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 8.28e-03 | 612 | 5 | 2 | GO:0010975 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 8.33e-03 | 614 | 5 | 2 | GO:0010720 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 8.63e-03 | 625 | 5 | 2 | GO:0051960 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 9.67e-03 | 663 | 5 | 2 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 9.70e-03 | 664 | 5 | 2 | GO:0099177 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 5.38e-04 | 155 | 5 | 2 | GO:0098685 | |
| MousePheno | abnormal spatial learning | 7.39e-05 | 276 | 5 | 3 | MP:0001463 | |
| MousePheno | increased exploration in new environment | 1.12e-03 | 150 | 5 | 2 | MP:0001415 | |
| Domain | PTPc | 3.60e-05 | 36 | 5 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 4.23e-05 | 39 | 5 | 2 | PS50055 | |
| Domain | PTPase_domain | 4.68e-05 | 41 | 5 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 4.68e-05 | 41 | 5 | 2 | PF00102 | |
| Domain | Tyr_Pase_cat | 9.75e-05 | 59 | 5 | 2 | IPR003595 | |
| Domain | PTPc_motif | 9.75e-05 | 59 | 5 | 2 | SM00404 | |
| Domain | Tyr_Pase_AS | 1.50e-04 | 73 | 5 | 2 | IPR016130 | |
| Domain | TYR_PHOSPHATASE_1 | 2.08e-04 | 86 | 5 | 2 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 2.13e-04 | 87 | 5 | 2 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 2.13e-04 | 87 | 5 | 2 | IPR000387 | |
| Domain | - | 2.38e-04 | 92 | 5 | 2 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.75e-04 | 99 | 5 | 2 | IPR029021 | |
| Domain | fn3 | 7.35e-04 | 162 | 5 | 2 | PF00041 | |
| Domain | FN3 | 9.57e-04 | 185 | 5 | 2 | SM00060 | |
| Domain | I-set | 1.01e-03 | 190 | 5 | 2 | PF07679 | |
| Domain | Ig_I-set | 1.01e-03 | 190 | 5 | 2 | IPR013098 | |
| Domain | FN3 | 1.11e-03 | 199 | 5 | 2 | PS50853 | |
| Domain | FN3_dom | 1.22e-03 | 209 | 5 | 2 | IPR003961 | |
| Domain | Ig_sub2 | 1.54e-03 | 235 | 5 | 2 | IPR003598 | |
| Domain | IGc2 | 1.54e-03 | 235 | 5 | 2 | SM00408 | |
| Domain | Ig_sub | 4.85e-03 | 421 | 5 | 2 | IPR003599 | |
| Domain | IG | 4.85e-03 | 421 | 5 | 2 | SM00409 | |
| Domain | IG_LIKE | 6.54e-03 | 491 | 5 | 2 | PS50835 | |
| Domain | Ig-like_dom | 6.86e-03 | 503 | 5 | 2 | IPR007110 | |
| Domain | - | 1.17e-02 | 663 | 5 | 2 | 2.60.40.10 | |
| Domain | Ig-like_fold | 1.32e-02 | 706 | 5 | 2 | IPR013783 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.91e-05 | 20 | 5 | 2 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.91e-05 | 20 | 5 | 2 | MM14991 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.91e-05 | 20 | 5 | 2 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 2.11e-05 | 21 | 5 | 2 | M27736 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.28e-04 | 335 | 5 | 3 | MM14503 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.20e-04 | 67 | 5 | 2 | MM15327 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.36e-04 | 411 | 5 | 3 | M735 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.72e-04 | 87 | 5 | 2 | M27617 | |
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 7665159 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 4.96e-08 | 3 | 5 | 2 | 31985401 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 9784606 | ||
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 4.96e-08 | 3 | 5 | 2 | 33656439 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 25703008 | ||
| Pubmed | 9.92e-08 | 4 | 5 | 2 | 8524829 | ||
| Pubmed | 1.65e-07 | 5 | 5 | 2 | 22357843 | ||
| Pubmed | 1.65e-07 | 5 | 5 | 2 | 10777529 | ||
| Pubmed | 2.48e-07 | 6 | 5 | 2 | 19273906 | ||
| Pubmed | 3.47e-07 | 7 | 5 | 2 | 12376545 | ||
| Pubmed | 3.47e-07 | 7 | 5 | 2 | 29073098 | ||
| Pubmed | 4.63e-07 | 8 | 5 | 2 | 37591863 | ||
| Pubmed | 4.63e-07 | 8 | 5 | 2 | 28637841 | ||
| Pubmed | 9.09e-07 | 11 | 5 | 2 | 25624497 | ||
| Pubmed | 9.09e-07 | 11 | 5 | 2 | 7832766 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 1.09e-06 | 12 | 5 | 2 | 9624153 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 2.25e-06 | 17 | 5 | 2 | 19727691 | |
| Pubmed | 5.37e-06 | 26 | 5 | 2 | 36178190 | ||
| Interaction | OMG interactions | 3.84e-06 | 13 | 5 | 2 | int:OMG | |
| Interaction | PIANP interactions | 6.69e-06 | 17 | 5 | 2 | int:PIANP | |
| Interaction | LINGO2 interactions | 9.34e-06 | 20 | 5 | 2 | int:LINGO2 | |
| Interaction | RNF133 interactions | 1.47e-05 | 25 | 5 | 2 | int:RNF133 | |
| Interaction | TIGIT interactions | 1.60e-05 | 26 | 5 | 2 | int:TIGIT | |
| Interaction | KCNC3 interactions | 1.99e-05 | 29 | 5 | 2 | int:KCNC3 | |
| Interaction | IZUMO1 interactions | 2.28e-05 | 31 | 5 | 2 | int:IZUMO1 | |
| Interaction | PPFIA2 interactions | 3.27e-05 | 37 | 5 | 2 | int:PPFIA2 | |
| Interaction | PCDHB16 interactions | 4.02e-05 | 41 | 5 | 2 | int:PCDHB16 | |
| Interaction | IL1RAP interactions | 4.64e-05 | 44 | 5 | 2 | int:IL1RAP | |
| Interaction | TMEM150A interactions | 5.30e-05 | 47 | 5 | 2 | int:TMEM150A | |
| Interaction | MAFF interactions | 5.76e-05 | 49 | 5 | 2 | int:MAFF | |
| Interaction | PPFIA3 interactions | 7.82e-05 | 57 | 5 | 2 | int:PPFIA3 | |
| Interaction | RELT interactions | 1.02e-04 | 65 | 5 | 2 | int:RELT | |
| Interaction | CD83 interactions | 1.05e-04 | 66 | 5 | 2 | int:CD83 | |
| Interaction | LPAR6 interactions | 1.11e-04 | 68 | 5 | 2 | int:LPAR6 | |
| Interaction | CLDND1 interactions | 1.18e-04 | 70 | 5 | 2 | int:CLDND1 | |
| Interaction | MRAP2 interactions | 1.43e-04 | 77 | 5 | 2 | int:MRAP2 | |
| Interaction | MARCHF2 interactions | 1.43e-04 | 77 | 5 | 2 | int:MARCHF2 | |
| Interaction | GPC4 interactions | 1.51e-04 | 79 | 5 | 2 | int:GPC4 | |
| Interaction | CEACAM21 interactions | 1.58e-04 | 81 | 5 | 2 | int:CEACAM21 | |
| Interaction | SCN2B interactions | 2.18e-04 | 95 | 5 | 2 | int:SCN2B | |
| Interaction | TRIO interactions | 2.87e-04 | 109 | 5 | 2 | int:TRIO | |
| Interaction | PTPRD interactions | 4.14e-04 | 131 | 5 | 2 | int:PTPRD | |
| Interaction | CBR1 interactions | 4.86e-04 | 142 | 5 | 2 | int:CBR1 | |
| Interaction | IRS1 interactions | 5.07e-04 | 145 | 5 | 2 | int:IRS1 | |
| Interaction | PTPRS interactions | 5.64e-04 | 153 | 5 | 2 | int:PTPRS | |
| Interaction | PTPRA interactions | 6.48e-04 | 164 | 5 | 2 | int:PTPRA | |
| Interaction | MTNR1A interactions | 6.64e-04 | 166 | 5 | 2 | int:MTNR1A | |
| Interaction | OPALIN interactions | 1.05e-03 | 209 | 5 | 2 | int:OPALIN | |
| Interaction | RYK interactions | 1.08e-03 | 212 | 5 | 2 | int:RYK | |
| Interaction | PPFIA1 interactions | 1.10e-03 | 214 | 5 | 2 | int:PPFIA1 | |
| Interaction | PTPRF interactions | 1.30e-03 | 233 | 5 | 2 | int:PTPRF | |
| Interaction | FFAR1 interactions | 1.32e-03 | 235 | 5 | 2 | int:FFAR1 | |
| Interaction | ACE2 interactions | 1.52e-03 | 1106 | 5 | 3 | int:ACE2 | |
| Interaction | TGFBR2 interactions | 1.81e-03 | 275 | 5 | 2 | int:TGFBR2 | |
| Interaction | FYN interactions | 4.37e-03 | 431 | 5 | 2 | int:FYN | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 7.70e-06 | 21 | 4 | 2 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 4.62e-04 | 160 | 4 | 2 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.67e-04 | 161 | 4 | 2 | 593 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 2.62e-05 | 43 | 5 | 2 | M1551 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 2.62e-05 | 43 | 5 | 2 | MM666 | |
| Coexpression | RAPA_EARLY_UP.V1_UP | 3.98e-04 | 167 | 5 | 2 | M2644 | |
| Coexpression | GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 4.83e-04 | 184 | 5 | 2 | M9219 | |
| Coexpression | PRC2_EZH2_UP.V1_DN | 5.26e-04 | 192 | 5 | 2 | M2737 | |
| Coexpression | GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP | 5.59e-04 | 198 | 5 | 2 | M5371 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP | 5.71e-04 | 200 | 5 | 2 | M8112 | |
| Coexpression | GSE3982_MAC_VS_BCELL_UP | 5.71e-04 | 200 | 5 | 2 | M5494 | |
| Coexpression | GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP | 5.71e-04 | 200 | 5 | 2 | M5503 | |
| Coexpression | AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2 | 6.84e-04 | 219 | 5 | 2 | M39111 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.90e-04 | 134 | 5 | 2 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | 4.67e-04 | 780 | 5 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | 5.03e-04 | 800 | 5 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | 6.66e-04 | 880 | 5 | 3 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | 6.75e-04 | 884 | 5 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.66e-04 | 188 | 5 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#2 | 7.66e-04 | 188 | 5 | 2 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K2 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.28e-05 | 138 | 5 | 2 | 10c263c58b83a018791f77098f18927d904cb13b | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.83e-05 | 142 | 5 | 2 | f7d0d5ca9fc3dd929d4fdd59b71bfa623007e992 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.83e-05 | 142 | 5 | 2 | 2a9a070e7c53ac593d46c6c5f6983f07d4413501 | |
| ToppCell | E15.5-Hematopoietic-Erythroid-enucleate_erythrocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.97e-05 | 143 | 5 | 2 | e4207ff9e8248813356631631bbf31a63f23ad3c | |
| ToppCell | E15.5-Hematopoietic-Erythroid|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.97e-05 | 143 | 5 | 2 | 15a7b93c381ef0f455f99f3abf4b2b9454d35bc4 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 146 | 5 | 2 | a5c84ad44d6ffb25028a4fd5454fd5de81b16a5e | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 146 | 5 | 2 | 8133037881c15e75637fc616091a7055488dd5fc | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-04 | 147 | 5 | 2 | 1ecd7c084e73eb6fae1ab1f9aae17115d3d62cbd | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 149 | 5 | 2 | 59aa1f2a5cbeba64c4529fb05f544db17fd8b188 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 149 | 5 | 2 | 1527cdd98a2734cbf8ce4c6170557280b71c55cb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 1.08e-04 | 149 | 5 | 2 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 150 | 5 | 2 | ccb782fbcb3122266354a112a9a850506664f44d | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 150 | 5 | 2 | 7290e9a812b1b2f919e67ccde0acf52687ab138f | |
| ToppCell | LPS_only-Hematopoietic_Mast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-04 | 150 | 5 | 2 | 2c5078a1f769ba8153dee756b53d28eb7b434a96 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-04 | 151 | 5 | 2 | b85a763459a0f019d1f9975d09b9f2247d62c9d3 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 156 | 5 | 2 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 157 | 5 | 2 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.23e-04 | 159 | 5 | 2 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 162 | 5 | 2 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 162 | 5 | 2 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | BAL-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 1.30e-04 | 163 | 5 | 2 | 7047d3ba847930f42a6d5f71e18d49f3071c6409 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-HSC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 164 | 5 | 2 | a35a0725b8bfe3cad5b85484217fd8a02bdee827 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-|GI_small-bowel / Manually curated celltypes from each tissue | 1.36e-04 | 167 | 5 | 2 | 7ff186b2bed3b0de93addb3b0ae5a2c6e44ddfb2 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.41e-04 | 170 | 5 | 2 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic-Meg|bone_marrow / Manually curated celltypes from each tissue | 1.44e-04 | 172 | 5 | 2 | deda14ba1e760dd46a5e129683d415436e74deb6 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.49e-04 | 175 | 5 | 2 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.49e-04 | 175 | 5 | 2 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 182 | 5 | 2 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 182 | 5 | 2 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 182 | 5 | 2 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 183 | 5 | 2 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.65e-04 | 184 | 5 | 2 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 185 | 5 | 2 | 0f722ffcc3e78d5c6b1b79d31d00929801a993f1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 185 | 5 | 2 | c985a4b184d382a79aaff07f81c0efede2c2d493 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 185 | 5 | 2 | d0d0e000ebe1fc35a987930ceaf7e3369e0c694c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 185 | 5 | 2 | 0ca99fcbd30c454bcdc2aa5265a0e4dba25666ea | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 187 | 5 | 2 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.85e-04 | 195 | 5 | 2 | 63e132fd6e4318299dd47bbe8ed3bf120efe46dd | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.85e-04 | 195 | 5 | 2 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 196 | 5 | 2 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| Drug | NSC-93090 | 5.50e-05 | 54 | 5 | 2 | CID000261166 | |
| Drug | synthetic pyrethrins | 9.53e-05 | 71 | 5 | 2 | CID000002982 | |
| Drug | glufosinate | 1.09e-04 | 76 | 5 | 2 | CID000004794 | |
| Drug | acrylonitrile | 1.12e-04 | 77 | 5 | 2 | CID000007855 | |
| Drug | Spotlight | 3.01e-04 | 126 | 5 | 2 | CID000086222 | |
| Drug | DMAB | 3.35e-04 | 133 | 5 | 2 | CID000006053 | |
| Drug | NSC71948 | 3.60e-04 | 138 | 5 | 2 | CID000415676 | |
| Drug | lithocholyltaurine | 5.79e-04 | 175 | 5 | 2 | CID000010595 | |
| Drug | 3-nitropropionic acid | 5.98e-04 | 178 | 5 | 2 | CID000001678 | |
| Drug | CTK8G2960 | 6.53e-04 | 186 | 5 | 2 | CID005361912 | |
| Drug | glutamate | 7.05e-04 | 962 | 5 | 3 | CID000000611 | |
| Drug | chloromethyl | 7.18e-04 | 195 | 5 | 2 | CID000007835 | |
| Drug | 4-dideoxy-1,4-imino-D-xylitol | 7.25e-04 | 196 | 5 | 2 | CID000001335 | |
| Drug | sulindac sulfone; Up 200; 50uM; MCF7; HG-U133A | 7.32e-04 | 197 | 5 | 2 | 314_UP | |
| Drug | DB07328 | 8.16e-04 | 208 | 5 | 2 | CID011840913 | |
| Drug | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | 8.39e-04 | 211 | 5 | 2 | ctd:C009618 | |
| Drug | AC1L1FHZ | 8.71e-04 | 215 | 5 | 2 | CID000003244 | |
| Drug | gossypol | 1.15e-03 | 247 | 5 | 2 | CID000003503 | |
| Drug | casticin | 1.19e-03 | 252 | 5 | 2 | ctd:C054133 | |
| Drug | spermidine | 1.20e-03 | 253 | 5 | 2 | CID000001102 | |
| Disease | azoospermia (implicated_via_orthology) | 8.05e-06 | 27 | 5 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | blood viscosity | 1.07e-05 | 31 | 5 | 2 | EFO_0004301 | |
| Disease | platelet measurement | 1.19e-05 | 315 | 5 | 3 | EFO_0005036 | |
| Disease | cannabis dependence | 2.06e-04 | 135 | 5 | 2 | EFO_0007191 | |
| Disease | mean reticulocyte volume | 6.94e-03 | 799 | 5 | 2 | EFO_0010701 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVLMMKFYDAPYEYE | 1486 | Q00975 | |
| DPFIDPEYMVYMFKY | 106 | O14556 | |
| YQYFVVDPMAEYNMP | 1761 | P10586 | |
| YQYFVVDPMAEYNMP | 1766 | P23468 | |
| EYVEMYPVEYPYSLM | 171 | Q16621 |